Ke Su Selected Research

vasodilator-stimulated phosphoprotein

1/2015	The Ultrastructure of MCF-7 Breast Cancer Cells after Vasodilator-Stimulated Phosphoprotein Knockdown.
8/2013	Matrine inhibits the adhesion and migration of BCG823 gastric cancer cells by affecting the structure and function of the vasodilator-stimulated phosphoprotein (VASP).
8/2012	MicroRNA-610 inhibits the migration and invasion of gastric cancer cells by suppressing the expression of vasodilator-stimulated phosphoprotein.
6/2012	HIF-1α acts downstream of TNF-α to inhibit vasodilator-stimulated phosphoprotein expression and modulates the adhesion and proliferation of breast cancer cells.
12/2011	Vasodilator-stimulated phosphoprotein regulates osteosarcoma cell migration.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ke Su Research Topics

Disease

15	Neoplasms (Cancer) 01/2022 - 12/2011
8	Breast Neoplasms (Breast Cancer) 10/2021 - 06/2012
6	Neoplasm Metastasis (Metastasis) 10/2021 - 12/2011
3	Inflammation (Inflammations) 10/2021 - 06/2012
3	Knee Osteoarthritis 01/2019 - 01/2017
3	Pain (Aches) 12/2017 - 01/2017
3	Stomach Neoplasms (Stomach Cancer) 08/2013 - 01/2012
2	Body Weight (Weight, Body) 01/2020 - 12/2018
2	Type 2 Diabetes Mellitus (MODY) 01/2020 - 11/2018
2	Osteoarthritis 01/2019 - 01/2017
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2018 - 08/2016
2	Hypoxia (Hypoxemia) 01/2014 - 06/2012
1	Ureteral Obstruction 10/2022
1	Fibrosis (Cirrhosis) 10/2022
1	Hepatocellular Carcinoma (Hepatoma) 07/2022
1	Rupture 01/2022
1	Coronary Disease (Coronary Heart Disease) 01/2022
1	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 01/2022
1	Prostatic Neoplasms (Prostate Cancer) 01/2021
1	COVID-19 10/2020
1	Triple Negative Breast Neoplasms 09/2020
1	Reperfusion Injury 09/2020
1	Myocardial Ischemia (Ischemic Heart Diseases) 09/2020
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2020
1	Spinal Dysraphism (Spina Bifida) 01/2020
1	Endometriosis 01/2020
1	Neural Tube Defects (Exencephaly) 01/2020
1	Carcinoma (Carcinomatosis) 09/2019
1	Lung Neoplasms (Lung Cancer) 04/2019
1	Squamous Cell Carcinoma of Head and Neck 02/2019
1	Ataxia Telangiectasia (Louis Bar Syndrome) 02/2019
1	Laryngeal Neoplasms (Laryngeal Cancer) 02/2019
1	Osteonecrosis (Kienbock's Disease) 02/2019
1	Spinal Cord Injuries (Spinal Cord Injury) 01/2019
1	Stroke (Strokes) 01/2019
1	Fracture Dislocation 01/2019
1	Osteoporotic Fractures 01/2019
1	B-Cell Lymphoma (Lymphoma, B Cell) 12/2018
1	Insulin Resistance 11/2018

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 01/2021 - 12/2011
5	vasodilator-stimulated phosphoproteinIBA 01/2015 - 12/2011
3	MicroRNAs (MicroRNA)IBA 02/2019 - 08/2012
3	Interleukin-17 (Interleukin 17)IBA 01/2019 - 01/2017
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2018 - 06/2012
3	CytokinesIBA 01/2017 - 06/2012
2	CholesterolIBA 01/2022 - 01/2020
2	Biological ProductsIBA 10/2021 - 01/2020
2	Transcription Factors (Transcription Factor)IBA 10/2021 - 12/2017
2	Pharmaceutical PreparationsIBA 01/2021 - 09/2020
2	Long Noncoding RNAIBA 09/2019 - 01/2018
1	artenimol (dihydroartemisinin)IBA 10/2022
1	Adenine FDA LinkGeneric 10/2022
1	Azacitidine (5 Azacytidine)FDA Link 10/2022
1	artemisinin (artemisinine)IBA 10/2022
1	DNA (Deoxyribonucleic Acid)IBA 10/2022
1	MethyltransferasesIBA 10/2022
1	Sorafenib (BAY 43-9006)FDA Link 07/2022
1	CollagenIBA 01/2022
1	Sirtuin 1IBA 10/2021
1	ChromatinIBA 10/2021
1	CateninsIBA 01/2021
1	Therapeutic UsesIBA 01/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021
1	Eukaryotic Initiation Factor-4EIBA 01/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	3- hydroxy- 17- (1H- benzimidazole- 1- yl)androsta- 5,16- dieneIBA 01/2021
1	HMGB1 Protein (HMG1)IBA 09/2020
1	Arachidonic Acid (Vitamin F)IBA 09/2020
1	Beclin-1IBA 01/2020
1	Liraglutide FDA Link 01/2020
1	TrehaloseIBA 01/2020
1	Triglycerides (Triacylglycerol)IBA 01/2020
1	LipidsIBA 01/2020
1	PhosphoproteinsIBA 04/2019
1	Phenobarbital (Luminal)FDA Link 04/2019
1	Glucose (Dextrose)FDA LinkGeneric 02/2019
1	Cisplatin (Platino)FDA LinkGeneric 02/2019
1	Sodium Chloride Symporter Inhibitors (Diuretics, Thiazide)IBA 01/2019
1	ThiazidesIBA 01/2019
1	tributyl phosphate (TBP)IBA 01/2019
1	CadmiumIBA 12/2018
1	Cadmium Chloride (Cadmium Dichloride)IBA 12/2018
1	Caspase 3 (Caspase-3)IBA 12/2018
1	ResistinIBA 11/2018
1	AdiponectinIBA 11/2018
1	insulin aspart protamine drug combination 30:70 insulin aspartIBA 11/2018
1	Biphasic InsulinsIBA 11/2018
1	Exenatide (Byetta)FDA Link 11/2018
1	Metformin (Glucophage)FDA LinkGeneric 11/2018
1	C-Reactive ProteinIBA 11/2018

Therapy/Procedure

4	Therapeutics 01/2021 - 08/2016
2	Stents 01/2022 - 01/2010
2	Immunotherapy 01/2022 - 01/2021
2	Intra-Articular Injections 05/2018 - 01/2017
1	Oral Administration 10/2022
1	Radiotherapy 07/2022
1	Suture Techniques 01/2022
1	Drug Therapy (Chemotherapy) 01/2021
1	Renal Dialysis (Hemodialysis) 10/2020
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 09/2020